Frank Mathias
Chief Executive Officer at OXFORD BIOMEDICA PLC
Network origin in Frank Mathias first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
33
| Public Company | Biotechnology | 33 |
| Public Company | Biotechnology | 21 | |
Université Pierre et Marie Curie
14
| Extinct | Other Consumer Services | 14 |
LEUKOCARE AG
 LEUKOCARE AG Medical/Nursing ServicesHealth Services LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany.
7
| Holding Company | Medical/Nursing Services | 7 |
Rentschler Biopharma SE
 Rentschler Biopharma SE Pharmaceuticals: MajorHealth Technology Rentschler Biopharma SE develops and produces pharmaceutical products. Its solutions include bioprocess development, bio manufacturing, associated consulting activities including cell line process, cell culture, aseptic filling, consulting, planning and project management services. The company was founded in 1927 and is headquartered in Laupheim, Germany.
6
| Subsidiary | Pharmaceuticals: Major | 6 |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Rentschler Biotechnologie Beteiligungs GmbH
 Rentschler Biotechnologie Beteiligungs GmbH Financial ConglomeratesFinance Part of Dr. Rentschler Holding GmbH & Co. KG, Rentschler Biotechnologie Beteiligungs GmbH is a German company that provides investment services. The company is based in Laupheim, Germany. The CEOs of the private company are Jürgen Müller, Nikolaus Friedrich Rentschler.
5
| Subsidiary | Financial Conglomerates | 5 |
Mediatum GmbH
3
| Private Company | 3 | |
August Faller GmbH & Co. KG
 August Faller GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services August Faller GmbH & Co. KG engages in the manufacture and supply of secondary packaging to the pharmaceutical, medical devices, and chemistry industry. It offers folding cartons, leaflets, labels, and combination products. The company was founded by August Faller in 1882 and is headquartered in Waldkirch, Germany.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Frank Mathias via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| BAYER AG | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| 4SC AG | Biotechnology | Director/Board Member Chief Executive Officer Chairman Investor Relations Contact | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
| UCB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| MORPHOSYS AG | Biotechnology | Director of Finance/CFO Director/Board Member Chief Tech/Sci/R&D Officer | |
| University of Oxford | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| Imperial College London | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chairman Founder | |
MediGene, Inc.
 MediGene, Inc. Pharmaceuticals: MajorHealth Technology MediGene, Inc. develops herpes simplex virus technologies for the treatment of tumors and for gene delivery. The company was founded by Ram Bhatt and Frank Tufaro and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| McGill University | College/University | Graduate Degree Undergraduate Degree | |
| BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | President Chief Executive Officer Director/Board Member | |
| University of British Columbia | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Investment Banks/Brokers | Director/Board Member Director/Board Member | |
| NEOVACS | Pharmaceuticals: Major | Founder Director/Board Member | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree | |
| Technical University of Berlin | College/University | Doctorate Degree Undergraduate Degree | |
| Université Paris 1 Panthéon-Sorbonne | College/University | Doctorate Degree Corporate Officer/Principal | |
Dr. Rentschler Holding GmbH & Co. KG
 Dr. Rentschler Holding GmbH & Co. KG Miscellaneous Commercial ServicesCommercial Services Dr. Rentschler Holding GmbH & Co. KG operates as a holding company with interests in pharmaceutical research and production. Its services include project management, cell line and process developing, as well as analytics and quality controlling solutions. The company was founded in 1927 and is headquartered in Laupheim, Germany. | Miscellaneous Commercial Services | Chief Executive Officer Chief Operating Officer Chairman Chief Executive Officer | |
| University of Regensburg | College/University | Doctorate Degree Undergraduate Degree | |
| École Normale Supérieure | College/University | Graduate Degree Undergraduate Degree | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Corporate Officer/Principal | |
| VIVORYON THERAPEUTICS N.V. | Biotechnology | Director/Board Member Director of Finance/CFO | |
| DMS IMAGING | Biotechnology | Chairman Director/Board Member | |
| Université Catholique de Louvain | College/University | Doctorate Degree Doctorate Degree | |
AMMA Venture GmbH
 AMMA Venture GmbH Engineering & ConstructionIndustrial Services AMMA Venture GmbH provides engineering services. The private company is based in Ingelheim, Germany. The CEOs are Mathias Albert Boehringer, Ramón Antonio Payano Baez. The German company was founded in 2007. | Engineering & Construction | Chief Executive Officer | |
CD-Venture GmbH
 CD-Venture GmbH Financial ConglomeratesFinance CD-Venture GmbH invests in the life sciences industry. The company was founded in 2003 and is headquartered in Heidelberg, Germany. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal | |
Proteros biostructures GmbH
 Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Proteros biostructures GmbH is a holding company which serves as a discovery service business. Its business areas are Discovery Pipeline, Discovery Services and Science & Technology. The Discovery Pipeline focuses on protein biochemistry, X-ray crystallography, biophysics, computational chemistry and property driven medicinal chemistry, Discovery Services offers drug discovery services with expertise and proprietary technologies for protein production, protein structure analysis, kinetic and thermodynamic profiling and Science & Technology segment focuses on industrialized structure-guided lead development infrastructure. The company was founded by Robert Huber and Torsten Neuefeind in 1999 and is headquartered in Martinsried, Germany. | Medical/Nursing Services | Director of Finance/CFO Director of Finance/CFO | |
Phorms Education SE
 Phorms Education SE Miscellaneous Commercial ServicesCommercial Services Phorms Education SE develops school locations by sourcing the necessary start-up funding, recruiting teachers and improving infrastructure. Its network includes seven German-English bilingual nurseries, primary, and secondary schools as well as the Heidelberg International School. The company was founded by Bea Beste in 2005 and is headquartered in Berlin, Germany. | Miscellaneous Commercial Services | Chairman | |
Themis Bioscience GmbH
 Themis Bioscience GmbH Pharmaceuticals: MajorHealth Technology Themis Bioscience GmbH operates as a biotechnology company, which engages in the development of prophylactic vaccinations from preclinical to early clinical phase. The firm focuses on the prevention of tropical infectious diseases. Its proprietary Themaxyn technology platform, in-licensed from Paris-based Institute Pasteur, forms the basis of all of the company's vaccine candidates. The company was founded by Erich Tauber in 2009 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| FORMYCON AG | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Cristal Delivery BV
 Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
Zytoprotec GmbH
 Zytoprotec GmbH Pharmaceuticals: MajorHealth Technology Zytoprotec GmbH develops and manufactures drugs for peritoneal dialysis. It specializes in the research and development of its pipeline, which encompasses PD-protec, a patented-protected solution and ICO-protec, a cytoprotective PD solution to address the market for non-glucose based PD solutions. The firm focus areas encompass portfolio management, therapeutic approach, patent management and research services. The company was founded by Karl Altenhuber, Christoph Aufricht and Christian Hoenig in 2007 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Medigene Immunotherapies GmbH
 Medigene Immunotherapies GmbH Pharmaceuticals: MajorHealth Technology Part of MediGene AG, Medigene Immunotherapies GmbH develops immunotherapy to treat cancer. The private company is based in Planegg, Germany. The German company was founded in 2013 by Thomas Blankenstein, Dolores J. Schendel. The CEO is Axel-Sven Malkomes. Medigene Immunotherapies was acquired by MediGene AG on January 27, 2014 for $13.05 million. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| INFLARX N.V. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
Chrimotha Immobilien GmbH
 Chrimotha Immobilien GmbH Real Estate DevelopmentFinance Chrimotha Immobilien GmbH is a company based in Ingelheim, Germany. The CEOs of the German company are Mathias Albert Boehringer, Christian Boehringer. | Real Estate Development | Chief Executive Officer | |
Chrimotha Immobilien GmbH & Co. KG
 Chrimotha Immobilien GmbH & Co. KG Real Estate DevelopmentFinance Chrimotha Immobilien GmbH & Co. KG provides real estate services. The private company is based in Ingelheim am Rhein, Germany. The CEOs are Mathias Albert Boehringer, Christian Boehringer. The German company was founded in 1995. | Real Estate Development | Chief Executive Officer | |
Rentschler Beteiligungs GmbH
 Rentschler Beteiligungs GmbH Financial ConglomeratesFinance Rentschler Beteiligungs GmbH is an investment holding German company. The private company is based in Laupheim, Germany. The CEOs are Nikolaus Friedrich Rentschler, Jürgen Müller. The company was founded in 1998. | Financial Conglomerates | Chief Executive Officer Chief Executive Officer | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Director/Board Member | |
| MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Director/Board Member | |
Vaximm AG
 Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
INJEX Pharma AG
 INJEX Pharma AG Medical SpecialtiesHealth Technology INJEX Pharma AG manufactures and sells needle free injections. Its product INJEX 30 is a needle free drug delivery system ready to be marketed worldwide to different medical markets. Injex Pharma's product uses in the fields of diabetes mellitus, local anesthesia and dental purposes. The company was founded by Andy Rösch in 1998 and is headquartered in Berlin, Germany. | Medical Specialties | Chairman Chief Executive Officer |
Statistics
International
| Germany | 23 |
| Switzerland | 7 |
| United States | 5 |
| United Kingdom | 5 |
| Canada | 5 |
Sectoral
| Health Technology | 27 |
| Consumer Services | 13 |
| Finance | 6 |
| Commercial Services | 5 |
| Process Industries | 2 |
Operational
| Director/Board Member | 327 |
| Corporate Officer/Principal | 151 |
| Independent Dir/Board Member | 86 |
| Chief Executive Officer | 77 |
| Chairman | 66 |
Most connected contacts
| Insiders | |
|---|---|
| Heather Elizabeth Preston | 34 |
| Jean-Paul Prieels | 32 |
| Catherine Moukheibir | 29 |
| Norbert Riedel | 29 |
| Michael Hayden | 27 |
| Hubert Birner | 27 |
| Gerhard Ries | 27 |
| Thomas Werner | 25 |
| Geneviéve B. Berger | 23 |
| Eliseo Salinas | 22 |
| David Lemus | 22 |
| Frederic Roch Doliveux | 21 |
| Andreas Rummelt | 18 |
| Michael M. Tarnow | 18 |
| Thomas Taapken | 16 |
- Stock Market
- Insiders
- Frank Mathias
- Company connections